• ELTROMBOPAG chembl:CHEMBL461101 Approved

    Alternate Names:

    REVOLADE
    ELTROMBOPAG
    SB497115
    SB-497115-GR
    ETB115
    3'-{(2Z)-2-[1-(3,4-DIMETHYLPHENYL)-3-METHYL-5-OXO-1,5-DIHYDRO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO}-2'-HYDROXYBIPHENYL-3-CARBOXYLIC ACID
    AMG531
    pubchem.compound:135449332
    chemidplus:496775-61-2
    rxcui:711942
    chembl:CHEMBL461101
    drugbank:06210

    Drug Info:

    FDA Approval approved
    Drug Class Small molecule
    Drug Indications thrombopoietic
    Year of Approval 2008
    Drug Class hematopoiesis stimulating agent
    Drug Categories bcrp/abcg2 inhibitors
    Drug Categories breast cancer resistance protein inhibitors
    Drug Categories cytochrome p-450 cyp2c8 inhibitors (moderate)
    Drug Categories cytochrome p-450 cyp2c8 inhibitors (strength unknown)
    Drug Categories cytochrome p-450 enzyme inhibitors
    Drug Categories cytochrome p-450 substrates
    Drug Categories hematinics
    Drug Categories increased megakaryocyte maturation
    Drug Categories increased platelet production
    Drug Categories oatp1b1/slco1b1 inhibitors
    Drug Categories organic anion transporting polypeptide 1b1 inhibitors
    Drug Categories thrombopoietin receptor agonist
    Drug Categories thrombopoietin receptor agonists
    Drug Categories ugt1a1 inhibitors
    Drug Categories ugt1a1 substrates
    Drug Categories ugt1a3 inhibitors
    Drug Categories ugt1a3 substrates
    Drug Categories ugt1a4 inhibitors
    Drug Categories ugt1a6 inhibitors
    Drug Categories ugt1a9 inhibitors
    Drug Categories ugt2b15 inhibitors
    Drug Categories ugt2b7 inhibitors
    (5 More Sources)